JA Dormandy, B Charbonnel, DJ Eckland, E Erdmann, M Massi-Benedetti, IK Moules, AM Skene, MH Tan, PJ Lefebvre, GD Murray, E Standl, RG Wilcox, L Wilhelmsen, J Betteridge, K Birkeland, A Gol.......
Context β-Blockers have been shown to decrease cardiovascular risk in patients with hypertension and type 2 diabetes mellitus (DM); however, some components of the metabolic syndrome are worsened by some β-bl.....